Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public

Biotechnology company Direct Biologics Inc. has signed a letter of intent to merge with Good Works II Acquisition Corp. (Nasdaq: GWII), the second SPAC with a charitable component launched by Fred Zeidman and his team.